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Persistent high stroke mortality in Bangladeshi
populations
Novel hypotheses to explain this need testing urgently
Censuses in 1981, 1991,
1–3 and 2001 (Wild et al.
Persistence of substantial inequalities in car-
diovascular disease mortality by country of
birth in England and Wales 2001-2003. Unpublished
manuscript). have shown that, among Bangladeshi-
born men living in the United Kingdom, the standard-
ised mortality ratio for stroke is two to three times the
population average, with less marked but important
excesses in Bangladeshi-born women. There has been
little progress in understanding the reasons for this
variation, let alone in identifying approaches to
improve outcomes. Lessons learnt about stroke among
British Bangladeshis may well apply to other
populations at high risk, including Indians and Pakista-
nis, whose excess stroke mortality is not quite so high.
In addition, such evidence could be highly relevant to
reducing health inequalities.
Is the excess mortality from stroke in Bangladeshis
explained by a higher case fatality ratio? Interim analy-
sis of data from the south London stroke register
shows no age adjusted difference in survival between
Bangladeshis and white Europeans (albeit based on a
small population), but does find an almost doubled age
adjusted incidence of stroke in Bangladeshis (Smeeton
N, personal communication of unpublished data from
Stewart et al4). Thus, these mortality data seem to
reflect a real excess that cannot be explained by a
higher case fatality.
To what extent, then, can these differences be
explained by an excess of risk factors for stroke?
Hypertension is the most important potential
explanation, but studies conducted in east London
and Newcastle found Bangladeshi adults to have on
average a mean systolic blood pressure that is 10 mm
Hg lower than that of white Europeans.5 6 These
regional findings have been confirmed by national
data from the Health Survey for England 1999 and a
recent systematic review.7 8 Total and low density
lipoprotein cholesterol concentrations are also com-
paratively low among Bangladeshis.5 6 Bangladeshi
men tend, however, to have a high prevalence of
diabetes, smoking, physical inactivity, and high serum
triglyceride concentrations, and low serum high
density lipoprotein cholesterol concentrations.2 5–7
For women, the burden from these risk factors is
also high, except for smoking, which is uncommon.2 6
Bangladeshis are also among the poorest of Britain’s
populations.
The Framingham stroke model and European
SCORE model both predict comparatively low rates
of stroke and cerebrovascular disease. For example, in
Bangladeshi men the Framingham model predicts the
incidence of stroke to be 52% (95% confidence inter-
val 35% to 77%) of that for the white European popu-
lation.3 We need to look beyond classic stroke risk
factors.
We suggest four specific lines of investigation that
warrant consideration—squatting and straining at
stool, vitamin D deficiency, infection, and the
combined impact of smoking and tobacco chewing.
Chakrabarti’s work on three groups—patients with
stroke, healthy volunteers, and hypertensive patients—
has identified squatting as a potential causal or
precipitating factor for stroke.9 Squatting is a fairly
common posture among South Asians and is known
to raise blood pressure by about 4-8 mm Hg with a
sustained effect during the period of squatting; impor-
tantly, this blood pressure rise is greatest in the central
vasculature.
Vitamin D deficiency is very common among
Bangladeshis in London, because of a diet lacking fish,
ghee, and eggs among both sexes and lack of exposure
to sunlight, particularly among women.10 Vitamin D
deficiency may raise the risk of stroke by increasing
insulin resistance and hypertension, or may worsen
outcomes after stroke by impairing neuroprotective
mechanisms.
Chronic inflammation is a well recognised risk
factor for stroke. A recent large case series reported
that the incidences of both myocardial infarction and
stroke were significantly raised in the few days after
acute infection, particularly of the respiratory tract.11
Many Bangladeshis in the UK live in overcrowded
households, with consequent increased risk of respira-
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tory tract infection: this possible link to stroke now
needs to be investigated. This theory is supported by
data from the Newcastle Heart Project showing that
plasma concentrations of IgG and staphylococcal
toxin are significantly higher in South Asian than
European white populations.12 13
Although smoking is common in Bangladeshi men
and almost certainly contributes to explaining some of
the high risk, it is uncommon in Bangladeshi women.2 6
Chewing tobacco as paan (betel leaf) is common in
both sexes, however, and in future epidemiological
studies researchers should ascertain total tobacco con-
sumption, as well as using more stringent methods
than hitherto for collecting accurate data.14
We propose that the explanation for high rates of
stroke in Bangladeshis lies in their heavier burden of
some established risk factors, their socioeconomic
deprivation, and some novel risk factors that are yet to
be characterised. Pending deeper understanding of the
causes, doctors should be aware of the high risk of
stroke and stroke fatality in Bangladeshis even in the
absence of raised blood pressure.
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Diabetes and the quality and outcomes framework
Successful UK initiative highlights inequity of investments between sectors
The rapidly rising prevalence of diabetes in theUnited Kingdom demands an effectiveresponse from healthcare services.1 British
general practitioners were among the first doctors in
primary care worldwide to manage many aspects of
diabetes care in their own practices,2 and by the millen-
nium were providing systematic diabetes care.3
Primary care based interventions are cost effective—
countries with strong primary healthcare systems have
lower healthcare costs and healthier populations.4 The
2003 general medical services contract signalled the
government’s determination to invest in evidence
based interventions in primary care and to encourage
further expansion of chronic disease management,
including diabetes care, into general practice.5 The
contract introduced a quality and outcomes frame-
work, designed to monitor the quality of the delivery of
primary care.
In this week’s BMJ Campbell and colleagues report
that general practitioners were already improving
effective care for three of the diseases covered by the
framework.6 One of these was diabetes, which is
assessed by 18 clinical indicators in the general medical
services contract.7 Contract data shows the prevalence
of diabetes is 3.3% in England and Scotland, 3.8% in
Wales, and 2.8% in Northern Ireland, and in England
more than 93% of general practices achieved the maxi-
mum points for diabetes care.w1 Most participating
practices have set up active patient registers to facilitate
call and recall for consultations.
The new general medical services contract built on
the rigorous analyses undertaken to develop the four
national service frameworks for diabetes—one for
each country in the United Kingdom.8 The contract
negotiators insisted that the new contract would be
the same throughout the UK and largely ignored the
patient focused elements such as information,
education, and empowerment in the frameworks. The
contract focuses on pharmaceutical interventions
Extra references w1-w4 appear on bmj.com
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